[Imatinib for pulmonary arterial hypertension]

Dtsch Med Wochenschr. 2014 Dec:139 Suppl 4:S151-4. doi: 10.1055/s-0034-1387457. Epub 2014 Dec 9.
[Article in German]
No abstract available

Publication types

  • Review

MeSH terms

  • Benzamides / adverse effects
  • Benzamides / therapeutic use*
  • Germany
  • Humans
  • Hypertension, Pulmonary / drug therapy*
  • Hypertension, Pulmonary / mortality
  • Imatinib Mesylate
  • Off-Label Use
  • Piperazines / adverse effects
  • Piperazines / therapeutic use*
  • Protein Kinase Inhibitors / adverse effects
  • Protein Kinase Inhibitors / therapeutic use*
  • Pyrimidines / adverse effects
  • Pyrimidines / therapeutic use*
  • Randomized Controlled Trials as Topic
  • Survival Rate
  • Ventricular Dysfunction, Right / drug therapy
  • Ventricular Dysfunction, Right / mortality

Substances

  • Benzamides
  • Piperazines
  • Protein Kinase Inhibitors
  • Pyrimidines
  • Imatinib Mesylate